Terrance McGuire's Net Worth

$766 Thousand

Who is Terrance McGuire?

Terrance McGuire does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include TechTarget Inc, ALNYLAM PHARMACEUTICALS, INC., POLARIS INDUSTRIES INC/MN, MOMENTA PHARMACEUTICALS INC, Phreesia, Inc., ACUSPHERE INC, LogMeIn, Inc., BIND Therapeutics, Inc, Seer, Inc., Invivyd, Inc., Pulmatrix, Inc., Alector, Inc., IRONWOOD PHARMACEUTICALS INC, TREVENA INC, Lyra Therapeutics, Inc., Cyclerion Therapeutics, Inc., ALIMERA SCIENCES INC, Arsanis, Inc., ACCELERON PHARMA INC, INTERNET BRANDS, INC., Sirtris Pharmaceuticals, Inc., DECODE GENETICS INC, and Tectonic Therapeutic, Inc..

SEC CIK

Terrance McGuire's CIK is 0001117003

Past Insider Trading and Trends

2017 was Terrance McGuire's most active year for acquiring shares with 10 total transactions. Terrance McGuire's most active month to acquire stocks was the month of May. 2014 was Terrance McGuire's most active year for disposing of shares, totalling 1 transactions. Terrance McGuire's most active month to dispose stocks was the month of March. 2018 saw Terrance McGuire paying a total of $0.00 for 150,868 shares, this is the most they've acquired in one year. In 2014 Terrance McGuire cashed out on 29,117 shares for a total of $0.00, their largest year based on trade value.